Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s stock price shot up 1.8% during trading on Tuesday. The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares were traded during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The business has a fifty day simple moving average of C$0.58 and a 200 day simple moving average of C$0.58. The firm has a market cap of C$18.19 million, a price-to-earnings ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- There’s a New Q in Town: Invesco’s ETF Targets International Innovators
- Boarding Now—GE Aerospace’s Earnings Beat Comes With a Catch
- AI Spending Is Surging—But Which Stocks Still Win if It Slows Down?
- Are RTX Corporation and Northrop Grumman Ready to Break Out?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
